Inactive Instrument

SEAE HLDG

Equities

SPNE

US81255T1088

SeaSpine Holdings Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022

March 06, 2023 at 04:01 pm EST

SeaSpine Holdings Corporation reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was USD 63.37 million compared to USD 55.59 million a year ago. Net loss was USD 18.96 million compared to USD 18.79 million a year ago. Basic loss per share from continuing operations was USD 0.51 compared to USD 0.52 a year ago. Diluted loss per share from continuing operations was USD 0.51 compared to USD 0.52 a year ago.
For the full year, sales was USD 237.53 million compared to USD 191.45 million a year ago. Net loss was USD 65.01 million compared to USD 54.35 million a year ago. Basic loss per share from continuing operations was USD 1.76 compared to USD 1.62 a year ago. Diluted loss per share from continuing operations was USD 1.76 compared to USD 1.62 a year ago.

Latest news about SEAE HLDG

SeaSpine Holdings Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-06	CI
SeaSpine Holdings Corporation(NasdaqGS:SPNE) dropped from S&P Global BMI Index	23-01-05	CI
SeaSpine Holdings Corporation(NasdaqGS:SPNE) dropped from S&P TMI Index	23-01-05	CI
Orthofix Medical, SeaSpine Holdings Complete Merger	23-01-04	MT
SeaSpine Holdings Corporation(NasdaqGS:SPNE) dropped from NASDAQ Composite Index	23-01-04	CI
Orthofix Medical Inc. completed the acquisition of SeaSpine Holdings Corporation from a group of shareholders in a merger of equals transaction.	23-01-03	CI
SeaSpine Achieves Placement Milestone for 7D Flash Navigation System	22-12-28	MT
SeaSpine Holdings Corporation Announces 100th Placement of 7D FLASH™ Navigation System	22-12-27	CI
North American Morning Briefing : Stock Futures Pause as More Key Data Eyed	22-12-01	DJ
Orthofix Medical Says It Has Received Nonbinding Takeover Offer From Two Private Equity Firms	22-12-01	MT
Stocks to Watch : Salesforce, Splunk, Okta, Sturm Ruger, Orthofix Medical	22-11-30	DJ
Orthofix Medical, SeaSpine Name CFO for Combined Company	22-11-18	MT
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing	22-11-18	CI
North American Morning Briefing : Futures Held -3-	22-11-03	DJ
Truist Securities Downgrades SeaSpine Holdings to Hold From Buy, Cuts Price Target to $6.75 From $12	22-11-02	MT
Transcript : SeaSpine Holdings Corporation, Q3 2022 Earnings Call, Nov 01, 2022	22-11-01
Earnings Flash (SPNE) SEASPINE HOLDINGS CORPORATION Reports Q3 Revenue $67.1M	22-11-01	MT
SeaSpine Holdings Corporation Provides Revenue Guidance for the Year 2022	22-11-01	CI
SeaSpine Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-01	CI
SeaSpine Holdings Corporation Launches Mariner MIS Wayfinder System	22-10-31	CI
SeaSpine Holdings Corporation Announces the Full Commercial Launch of the 7D FLASH™ Navigation System Percutaneous Spine Module	22-10-18	CI
Top Midday Decliners	22-10-11	MT
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	22-10-11	MT
Orthofix Medical, SeaSpine Holdings Corporation to Combine in All-Stock Merger of Equals	22-10-11	MT
Top Premarket Decliners	22-10-11	MT

Chart SEAE HLDG

Duration

Period

More charts

Company Profile

SeaSpine Holdings Corporation is a global medical technology company. The Company is focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It offers a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products consist of a range of advanced and traditional bone graft substitutes designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip, and extremities procedures. The Company's spinal implants and enabling technologies portfolio consists of a line of products and image-guided surgical solutions to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures.

Sector

More about the company